Activation of cerebral endothelium is required for mononuclear cell recruitment in a novel in vitro model of brain inflammation

Neuroscience ◽  
2006 ◽  
Vol 137 (4) ◽  
pp. 1211-1219 ◽  
Author(s):  
L. Librizzi ◽  
S. Mazzetti ◽  
C. Pastori ◽  
S. Frigerio ◽  
A. Salmaggi ◽  
...  
2009 ◽  
Vol 6 (1) ◽  
pp. 15 ◽  
Author(s):  
Antoinette Defaux ◽  
Marie-Gabrielle Zurich ◽  
Olivier Braissant ◽  
Paul Honegger ◽  
Florianne Monnet-Tschudi

2020 ◽  
Vol 21 (15) ◽  
pp. 5293
Author(s):  
Angélica Aponte-López ◽  
Jennifer Enciso ◽  
Samira Muñoz-Cruz ◽  
Ezequiel M. Fuentes-Pananá

Breast cancer (BrC) affects millions of women yearly. Mast cells (MCs) are common components of breast tumors with documented agonistic and antagonistic roles in tumor progression. Understanding the participation of MCs in BrC may lead to new therapies to control tumor growth. In this study, we looked into mechanistic models of MC responses triggered by BrC cells (BrCC), assessing both early degranulation and late transcriptional activities. We used aggressive and non-aggressive BrCC to model the progressive staging of the disease over HMC1 and LAD-2 human MC lines. We found that both MC lines were chemoattracted by all BrCC, but their activation was preferentially induced by aggressive lines, finding differences in their active transcriptional programs, both at basal level and after stimulation. Among those genes with altered expression were down-regulated SPP1, PDCD1, IL17A and TGFB1 and up-regulated KITLG and IFNG. A low expression of SPP1 and a high expression of KITLG and IFNG were associated with increased overall survival of BrC patients from public databases. The set of altered genes is more often associated with tumor stromas enriched with anti-tumoral signals, suggesting that MCs may participate in tumor control.


2010 ◽  
Vol 7 (1) ◽  
pp. 30 ◽  
Author(s):  
Henrik Wilms ◽  
Jobst Sievers ◽  
Uta Rickert ◽  
Martin Rostami-Yazdi ◽  
Ulrich Mrowietz ◽  
...  

Author(s):  
Hoda Keshmiri Neghab ◽  
Mohammad Hasan Soheilifar ◽  
Gholamreza Esmaeeli Djavid

Abstract. Wound healing consists of a series of highly orderly overlapping processes characterized by hemostasis, inflammation, proliferation, and remodeling. Prolongation or interruption in each phase can lead to delayed wound healing or a non-healing chronic wound. Vitamin A is a crucial nutrient that is most beneficial for the health of the skin. The present study was undertaken to determine the effect of vitamin A on regeneration, angiogenesis, and inflammation characteristics in an in vitro model system during wound healing. For this purpose, mouse skin normal fibroblast (L929), human umbilical vein endothelial cell (HUVEC), and monocyte/macrophage-like cell line (RAW 264.7) were considered to evaluate proliferation, angiogenesis, and anti-inflammatory responses, respectively. Vitamin A (0.1–5 μM) increased cellular proliferation of L929 and HUVEC (p < 0.05). Similarly, it stimulated angiogenesis by promoting endothelial cell migration up to approximately 4 fold and interestingly tube formation up to 8.5 fold (p < 0.01). Furthermore, vitamin A treatment was shown to decrease the level of nitric oxide production in a dose-dependent effect (p < 0.05), exhibiting the anti-inflammatory property of vitamin A in accelerating wound healing. These results may reveal the therapeutic potential of vitamin A in diabetic wound healing by stimulating regeneration, angiogenesis, and anti-inflammation responses.


2011 ◽  
Vol 71 (05) ◽  
Author(s):  
M Salama ◽  
K Winkler ◽  
KF Murach ◽  
S Hofer ◽  
L Wildt ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document